The case for & against
Bull & Bear analysis
Bearish
Assure Holdings Corp. (NASDAQ: IONM) operates within the healthcare sector, focusing on intraoperative neuromonitoring services, which provide essential monitoring for neurological functions during surgical procedures. The company is currently navigating a challenging reimbursement landscape while positioning itself for potential market growth through operational efficiency and strategic expansion, particularly amid recovery from COVID-19 disruptions.
Bull says
- ↑Managed case volume reached 21,557 procedures in 2022 (+24% YoY), signaling strong demand
- ↑Operating expenses reduced by $1.2M (26% YoY), aiming for over $5M in annual savings
- ↑Cash collections improved to ~$21M in 2022, with DSO down from 61 to 46 days
- ↑Higher-margin commercial cases and Innovation Neuromonitoring acquisition add ~3,000 surgeries/year
- ↑Maintains a 0.53% dividend yield and shows positive profitability metrics amid rising rates
Bear says
- ↓Insurance reimbursements fell ~67% over three years, pressuring revenue and margins
- ↓Recorded a $30.7M net loss in 2022; earnings yield remains negative
- ↓Bad debt expense rose to ~$2.5M, with AR reserve at 50% of gross receivables
- ↓Analysts’ earnings revisions are trending down, reflecting declining expectations
- ↓Only 23% of trading days were positive in the last 30 days, underscoring bearish sentiment
Earnings Call · Q2 2022 · Mgmt. Guidance
Updated 09-11-2026neutral
Transcript signals
Bull points
- Assure continued to generate strong procedure growth up 36% to $5,800.
- Our revenue accrual rate has remained stable in our key high volume markets, reinforcing our business fundamentals and revenue recognition.
- Our operating expenses decreased to 4.1 million compared to 4.5 million. And as referenced earlier, we expect operating expenses to be further reduced in the third and fourth quarters.
Bear points
- Assure reported gross revenue of $9.2 million and net revenue of $1.6 million, adjusted EBITDA loss of $5.9 million and net loss of $4.7 million.
- The previously mentioned reserve of aid receivables was netted against current quarter revenue and negatively impacted our financial results.
- Q2 typically experiences seasonality due to a less favorable revenue mix between government and commercial insurance, which reverses as the year progresses and case volumes increase.
Read full transcript analysis ›